It is the quiet before the storm. At the end of March, the future of renal denevation will be decided with the presentation of the Simplicity HTN-3 clinical trial at the American College of Cardiology meeting in Washington.
Today is World Cancer Day 2014 and COCIR wants to take this opportunity to raise awareness of what our sector (medical imaging and health ICT) is contributing to the fight against cancer, by providing solutions for the prevention, early diagnosis and treatment of this devastating, ever-rising chronic disease.
Cancer diagnostics - Nanotechnology is currently being used in oncology to improve early tumour detection, imaging procedures and targeting of cancer therapies. Cancer biomarkers, indicators that are being produced by the body in spreading tumour cells, play an important role in cancer detection, Dr. Jörg Raach reports
Neurologists keenly debate the value of mechanical reopening of blocked blood vessels in the brain, as demonstrated during the 21st World Congress for Neurology (WCN) in Vienna this September. Theoretically, endovascular thrombolysis can only be considered for 20-30% of all incidents of stroke.
This year a further one in six of England’s hospitals started to offer patients the choice of ‘self-funding’ for treatments and services that are subject to restrictions or long NHS waiting times. These include IVF treatment, cataract surgery, varicose veins, carpal tunnel syndrome therapy and hernia repair.
Nothing new has been invented in heart failure in the last 15 years, according to Christian Homsy, CEO of Belgian-based Cardio3 Biosciences. This explains the excitement surrounding an emerging treatment among cardiologists, patients and investors.
A major new cutting edge radiotherapy treatment will be available in the UK thanks to £250 million of government funding to build two new facilities in Manchester and London, Public Health Minister Anna Soubry confirmed on August, 1.
Working independently from different perspectives, geneticists from Finland and biochemists from Würzburg have researched the molecular mechanisms of schizophrenia and cognitive impairment.
Israel - Researchers are using breath-test technology to detect volatile organic compounds to tell whether a patient has stomach cancer.
In developed countries, bladder cancer is the fourth most frequent cancer in men and the ninth in women, and it greatly challenges patient management and cost containment. However, it is under-represented in public awareness and in cancer research.
There is little evidence on respiratory support with extracorporeal systems – enough of an argument for most of those doubting the procedure not to use it, or even make it available.
Current trends in the medical tourism industry indicate that the needs of international patients are challenging health service providers to come up with advanced solutions for quality healthcare outcomes.
A high unemployment rate coupled with an influx of refugees from Iraq and Syria has compounded challenges faced by the Jordanian government to provide healthcare for all, states a new report by healthcare experts GlobalData.
‘We aim to develop an understanding of which novel research activities could bring benefits for patients,’ explained Professor Christof von Kalle, Director of the Department of Translational Oncology, NCT (German National Centre for Tumour Diseases) and the German Cancer Research Centre (DKFZ), speaking on translational activities during the New Cancer Targets gathering in Heidelberg this…
A prototype for proton and ion therapy has been used clinically in Heidelberg since 2009. Built jointly by Siemens and GSI (Helmholtz Centre for Heavy Ion Research) in Darmstadt.
Patients with a migration background can create underestimated difficulties in healthcare systems in Western countries.
European doctors and scientists are working on the StrokeBack project, a medical system aimed at supporting stroke patients in their rehabilitation. Modern technology helps affected patients to practise their mobility at home.
IBA Group, a leader in advanced cancer diagnosis and therapy technologies, and Royal Philips Electronics (NYSE: PHG, AEX: PHI) today announced their first-ever installation of a state-of-the-art, patient-centered proton therapy treatment room in the United States.
EH Paris correspondent Annick Chapoy, reports on a French study that confirms the relevance of a drug with a long history in the management of other diseases
The world’s first gene cancer therapy study of an innovative oral vaccine is underway at the Surgical Clinic of Heidelberg University Hospital.
The list of post-operative complications is long. Most common are fever, chest infection, pneumonia, wound infection, bleeding or deep vein thrombosis. As these post-surgical complications can range from minor, self-limiting problems to major life-threatening events, their definition and severity staging can be challenging.
Using a mathematical formula that carefully measures the degree to which HIV infection of immune system cells is stalled by antiretroviral therapy, AIDS experts at Johns Hopkins have calculated precisely how well dozens of such anti-HIV drugs work, alone or in any of 857 likely combinations, in suppressing the virus.
Currently there is a truly enormous hole in the ground in the city of Wiener Neustadt, Austria, but by summer 2012 MedAustron, one of the most modern centres for ion therapy and research in Europe, is to be built here.
PBT uses a high-energy beam of particles to destroy cancer cells by more accurately targeting the affected areas and is particularly suitable for complex childhood cancers. It also increases success rates and reduces side effects, such as deafness, loss of IQ and secondary cancers.